Markov texture parameters as prognostic indicators in endometrial cancer

Gynecologic Oncology

Volumn 62, Issue 2, 1996, Pages 174-180

  Geisler, John P ^a   Wiemann, Michael C ^b   Zhou, Zhen ^c   Miller, Greg A ^c   Geisler, Hans E ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST VINCENT HOSPITAL   (United States)

^c Dept of Pathol Lab for D ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; ASCITES FLUID CYTOLOGY; CANCER GRADING; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; DNA DETERMINATION; ENDOMETRIUM CANCER; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; PROSPECTIVE STUDY;

EID: 0030220187     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.0212     Document Type: Article

References (17)

1. 1. Pressman, N. J. Markovian analysis of cervical cell images, J. Histochem. Cytochem. 24, 138-144 (1976).
2. 2. Creasman, W. T., and Rutledge, F. The prognostic value of peritoneal cytology in gynecologic malignant disease, Am. J. Obstet. Gynecol. 110, 773-781 (1972).
3. 3. Hanson, M. B., Van Nagell, J. R., Powell, D. E., Donaldson, E. S., Gallion, H., Merhige, M., and Pavlik, E. J. The prognostic significance of lymph-vascular space invasion in stage I endometrial cancer, Cancer 55, 1753-7 (1985).
4. 4. Geisinger, K. R., Homesley, H. D., Morgan, T. M., Kute, T. E., and Marshall, R. B. Endometrial carcinoma: A multip 11, 12, 13, arameter clinicopathologic analysis including the DNA profile and the sex steroid status, Cancer 58, 1518-1525 (1986).
5. 5. Iversen, O. E. Flow cytometric deoxyribonucleic acid index: A prognostic factor in endometrial carcinoma, Am. J. Obstet. Gynecol. 155, 770-776 (1986).
6. 6. Britton, L. C., Wilson, T. O., Gaffey, T. A., Cha, S. S., Wieand, H. S., and Podratz, K. C. DNA ploidy in endometrial carcinoma: Major objective prognostic factor, Mayo Clin. Proc. 65, 643-650 (1990).
7. 7. Newbury, R., Schuerch, C., Goodspeed, N., Fanning, J., Glidewell, O., and Evans, M. DNA content as a prognostic factor in endometrial carcinoma, Obstet. Gynecol. 76, 251-257 (1990).
8. 8. Moberger, B., Auer, G., Forsslund, G., and Moberger, G. The prognostic significance of DNA measurements in endometrial carcinoma, Cytometry 5, 430-436 (1984).
9. 9. Sorbe, B., Risberg, B., and Thornthwaite, J. Nuclear morphometry and DNA flow cytometry as prognostic methods for endometrial carcinoma, Int. J. Gynecol. Cancer 4, 94-100 (1994).
10. 10. Atkin, B. Prognostic significance of ploidy level in human tumors. I. Carcinoma of the uterus, J. Natl Cancer Inst. 56, 909-910 (1976).
11. 11. Bowman, R., and Hause, L. Selection of morphometric features that identify responders and nonresponders in stage IV Wilms' tumors, Anal. Quant. Cytol. Histol. 16, 90-94 (1994).
12. 12. Dawson, A. E., Cibas, E. S., Bacus, J. W., and Weinberg, D. S. Chromatin texture measurement by markovian analysis: Use of nuclear models to define and select texture features, Anal. Quant. Cytol. Histol. 15, 227-235 (1993).
13. 13. Van der Poel, H. G., Boon, M. E., Kok, L. P., van der Meulen, E. A., van Caubergh, R. D., de Bruijn, W. C., and Debruyne, F. M. J. Morphometry, densitometry and pattern analysis of plastic-embedded histologic material from urothelial cell carcinoma of the bladder, Anal. Quant. Cytol. Histol. 13, 307-315 (1991).
14. 14. Mendelsohn, M. L., and Mayall, B. H. Chromosome identification by image analysis and quantitative cytochemistry, in Human chromosome methodology (J. J. Junis, Ed.), Academic Press, New York, 2nd ed., pp. 311-346 (1974).
15. 15. Bacus, J. W., and Grace, L. J. Microscope system for standardized cell measurements and analyses, Appl. Optics 26, 3280-3293 (1987).
16. 16. Veltri, R. W., Partin, A. W., Epstein, J. E., Marley, G. M., Miller, C. M., Singer, D. S., Patton, K. P., Criley, S. R., and Coffey, D. S. Quantitative nuclear morphometry, markovian texture descriptors, and DNA content captured on a CAS-200 image analysis system, combined with PCNA and HER-2/neu immunohistochemistry for prediction of prostate cancer progression, J. Cell. Biochem. 19s, 249-58 (1994).
17. 17. King, E. B., Chew, K. L., and Duarte, N. L. Image cytometric classification of premalignant breast disease in fine needle aspirates, CA Cancer J. Clin. 62, 114-124 (1988).